Turku, Finland – 5 January 2022: DelSiTech Ltd, a Finnish drug delivery technology and development company announced today that Mr. Martti Hedman has been appointed to its Board of Directors, effective as of January 1, 2022.
Martti Hedman has 37 years of global business leadership experience having lived and held executive positions in the United States, United Kingdom, Germany, and Finland.
Mr. Hedman is the former Chief Executive Officer of Colorcon, Inc., which is a leading and globally operating, US-based, pharma-focused specialty product company. Prior to his CEO role, Mr. Hedman served Colorcon in multiple senior level operational and strategic roles, both in the USA and UK. After his CEO tenure, Mr. Hedman continued to hold a Board position at Colorcon and act as Advisor to Oliver-Tolas Healthcare Packaging, Inc. (US) throughout 2021. Before Colorcon, Mr. Hedman had business development roles at Helm AG Pharma in Germany and Orion Pharma in Finland.
“We are very pleased to welcome Martti Hedman to DelSiTech,” said Dr. Örjan Andersson, Chairman of DelSiTech’s Board of Directors. “Mr. Hedman has an extensive international career in the pharma industry and a deep understanding of B2B strategies and operations worldwide. He brings to our Board a considerable knowledge of global expansion, corporate governance and financing expertise, helping DelSiTech to reach the next level as a global drug delivery company.”
“DelSiTech has a unique and exciting business model that allows significant growth in the fields of drug delivery and drug development,” said Mr. Hedman. “I’m very confident in the company’s prospects, and I look forward to contributing to the success of DelSiTech.”